13.65
1
[1]. Jian Jin, et al. Serine threonine kinase (akt) degradation / disruption compounds and methods of use. Patent WO201913516A1.
[2]. Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;2(8):998-985.
[3]. Scheepstra M, et al. Bivalent Ligands for Protein Degradation in Drug Discovery. Comput Struct Biotechnol J. 2019;1:160-16. Published 2019 Jan 25.
P261-P26-P20-P21-P280-P302+P352-P30+P30-P305+P351+P338-P330-P362+P36-P03+P233-P05-P501
GHS0
![]()